Market Conditions Delay Sale of Stem Cell Bonds
The sale of $250 million in California state bonds to finance human embryonic stem cell research has been postponed from Sept. 27 to Oct. 4 to see if market conditions improve, providing a "better deal" for the state's taxpayers.
At this point, the delay looks like a pretty good move given the Federal Reserve Board's reduction in interest rates.
The Cali…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.